Archive · 24 Sep 2025
India to Revise Drug Standards, Aligning with Global Benchmarks
India is updating its drug quality rules to be as good as those in the US, Europe, and Japan.
This means the medicines made in India will have to meet stricter standards for safety and quality.
The government wants to make sure the medicines are safe and reliable.
This is important because India makes a lot of medicines for the world.
Updated standards will help ensure medicines are safe and effective, which will also make it easier for them to be sold around the world.
India is revising drug safety and quality standards to match US, EU, and Japanese benchmarks.
New standards will be set for 123 drugs, and existing standards will be updated for 200 more.
The Indian Pharmacopoeia Commission (IPC) is leading the effort to harmonize standards.
The goal is to boost confidence in Indian-made medicines and promote the country's pharma market.
Updated standards will be included in the upcoming 2026 edition of the Indian Pharmacopoeia.
- Who
- Indian Pharmacopoeia Commission (IPC)
- What
- Updating drug safety and quality standards
- When
- To be released shortly; 2026 edition of Indian Pharmacopoeia
- Where
- India
- Why
- To align with global standards and boost confidence in Indian-made medicines
- Industry Value
- $50 billion
- New Standards
- 123 drugs
- Updated Standards
- 200 medicines
- Countries using Indian Pharmacopoeia
- 14
- India's Generic Drug Supply
- 20% of global volume